The A1 Astrocyte Paradigm: New Avenues for Pharmacological Intervention in Neurodegeneration

Overview

Journal Mov Disord

Date 2019 May 29

PMID 31136698

Citations 44

Authors

Jared T Hinkle

Valina L Dawson

Ted M Dawson

Affiliations

Soon will be listed here.

Abstract

We recently demonstrated that NLY01, a novel glucagon-like peptide-1 receptor agonist, exerts neuroprotective effects in two mouse models of PD in a glia-dependent manner. NLY01 prevented microglia from releasing inflammatory mediators known to convert astrocytes into a neurotoxic A1 reactive subtype. Importantly, we provided evidence that this neuroprotection was not mediated by a direct action of NLY01 on neurons or astrocytes (e.g., by activating neurotrophic pathways or modulating astrocyte reactivity per se). In the present article, we provide a generalist review of microglia and astrocytes in neurodegeneration and discuss the emerging paradigm of A1 astrocyte neurotoxicity in more detail. We comment on specific inferences that are naturally suggested by our work in this area and the differential level of support it offers to each. Finally, we discuss implications for the overall goal of creating disease-modifying therapies for PD, survey emerging methodologies for accelerating translational research on glia in neurodegeneration, and describe expected challenges for developing glia-directed therapies that do not impede essential physiological functions carried out by glia in the CNS. © 2019 International Parkinson and Movement Disorder Society.

Citing Articles

Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson's disease model triggered by α-synuclein overexpression.

Zhang Z, Niu K, Huang T, Guo J, Xarbat G, Gong X NPJ Parkinsons Dis. 2025; 11(1):15.

PMID: 39779738 PMC: 11711755. DOI: 10.1038/s41531-024-00846-4.

Ghrelin Inhibits Inflammasomes Activation in Astrocytes, Alleviates Pyroptosis, and Prevents Lipopolysaccharide-induced Depression-like Behavior in Mice.

Han X, Fu X, Guo W, Liu Y, Sun J, Wang T Inflammation. 2024; .

PMID: 39702621 DOI: 10.1007/s10753-024-02190-4.

Neuroinflammation and major depressive disorder: astrocytes at the crossroads.

Puentes-Orozco M, Albarracin S, Velasquez M Front Cell Neurosci. 2024; 18:1504555.

PMID: 39650796 PMC: 11620873. DOI: 10.3389/fncel.2024.1504555.

Unveiling the multifaceted pathogenesis and therapeutic drugs of Alzheimer's disease: A comprehensive review.

Peng L, Zhang Z, Li Q, Song Z, Yan C, Ling H Heliyon. 2024; 10(20):e39217.

PMID: 39629139 PMC: 11612466. DOI: 10.1016/j.heliyon.2024.e39217.

Salidroside ameliorates cerebral ischemic injury and regulates the glutamate metabolism pathway in astrocytes.

Zheng X, Zhang H, Zhang Y, Ding Z, Huang Z, Li H Front Pharmacol. 2024; 15:1472100.

PMID: 39600364 PMC: 11588439. DOI: 10.3389/fphar.2024.1472100.

References

Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J . NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell. 2016; 164(5):896-910. PMC: 4769378. DOI: 10.1016/j.cell.2015.12.057. View

Dawson T, Golde T, Lagier-Tourenne C . Animal models of neurodegenerative diseases. Nat Neurosci. 2018; 21(10):1370-1379. PMC: 6615039. DOI: 10.1038/s41593-018-0236-8. View

Olmos-Alonso A, Schetters S, Sri S, Askew K, Mancuso R, Vargas-Caballero M . Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Brain. 2016; 139(Pt 3):891-907. PMC: 4766375. DOI: 10.1093/brain/awv379. View

Spangenberg E, Lee R, Najafi A, Rice R, Elmore M, Blurton-Jones M . Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. Brain. 2016; 139(Pt 4):1265-81. PMC: 5006229. DOI: 10.1093/brain/aww016. View

Dauer W, Przedborski S . Parkinson's disease: mechanisms and models. Neuron. 2003; 39(6):889-909. DOI: 10.1016/s0896-6273(03)00568-3. View

Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson V, Dawson T . Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A. 1996; 93(10):4565-71. PMC: 39317. DOI: 10.1073/pnas.93.10.4565. View

Lee M, Stirling W, Xu Y, Xu X, Qui D, Mandir A . Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A. 2002; 99(13):8968-73. PMC: 124407. DOI: 10.1073/pnas.132197599. View

Kim C, Ho D, Suk J, You S, Michael S, Kang J . Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013; 4:1562. PMC: 4089961. DOI: 10.1038/ncomms2534. View

Dawson T, Dawson V . The role of parkin in familial and sporadic Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S32-9. PMC: 4115293. DOI: 10.1002/mds.22798. View

10.

Kozina E, Sadasivan S, Jiao Y, Dou Y, Ma Z, Tan H . Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain. 2018; 141(6):1753-1769. PMC: 7190032. DOI: 10.1093/brain/awy077. View

11.

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland T . A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017; 169(7):1276-1290.e17. DOI: 10.1016/j.cell.2017.05.018. View

12.

Sakuta M . [One hundred books which build up neurology--Rudolf Ludwig Carl Virchow "Die Cellularpathologie in ihrer Begrundung auf physiologische und pathologische Gewebelehre"]. Brain Nerve. 2011; 63(2):184-5. View

13.

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

14.

Itoh N, Itoh Y, Tassoni A, Ren E, Kaito M, Ohno A . Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes. Proc Natl Acad Sci U S A. 2017; 115(2):E302-E309. PMC: 5777065. DOI: 10.1073/pnas.1716032115. View

15.

Grabert K, Michoel T, Karavolos M, Clohisey S, Baillie J, Stevens M . Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016; 19(3):504-16. PMC: 4768346. DOI: 10.1038/nn.4222. View

16.

Allen N, Bennett M, Foo L, Wang G, Chakraborty C, Smith S . Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature. 2012; 486(7403):410-4. PMC: 3383085. DOI: 10.1038/nature11059. View

17.

Mandir A, Przedborski S, Jackson-Lewis V, Wang Z, Simbulan-Rosenthal C, Smulson M . Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A. 1999; 96(10):5774-9. PMC: 21936. DOI: 10.1073/pnas.96.10.5774. View

18.

Surmeier D, Obeso J, Halliday G . Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci. 2017; 18(2):101-113. PMC: 5564322. DOI: 10.1038/nrn.2016.178. View

19.

Kano S, Choi E, Dohi E, Agarwal S, Chang D, Wilson A . Glutathione -transferases promote proinflammatory astrocyte-microglia communication during brain inflammation. Sci Signal. 2019; 12(569). PMC: 6637164. DOI: 10.1126/scisignal.aar2124. View

20.

Spiller K, Restrepo C, Khan T, Dominique M, Fang T, Canter R . Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci. 2018; 21(3):329-340. PMC: 5857237. DOI: 10.1038/s41593-018-0083-7. View